To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV. The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.
This phlebotomy protocol permits the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV. Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for one or all of the following tests: * T cell subset enumeration * Serologic reactivity with HIV antigens * Viral load assays by bDNA, PCR, or RT-PCR * Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR) * HIV-1 Resistance Testing These data are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines
Study Type
OBSERVATIONAL
Enrollment
600
* T cell subset enumeration * Serologic reactivity with HIV antigens * Viral load assays by bDNA, PCR, or RT-PCR * Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR) * HIV-1 Resistance Testing
Aaron Diamond AIDS Research Center (ADARC)
New York, New York, United States
Rockefeller University Hospital
New York, New York, United States
Participants are tested for HIV-1 RNA levels, the presence of antibodies to HIV antigens, and T cell subsets
Time frame: first visit
Data will be used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment
Time frame: first visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.